Market Place
Sourcing Support
BioSig Regains Compliance with Nasdaq Bid Price Requirement
13 Nov 2024 //
GLOBENEWSWIRE
BioSig Technologies’ Stock Resumes Trading On NASDAQ
22 Oct 2024 //
GLOBENEWSWIRE
BioSig Technologies To Acquire Neuro-Kinesis Corporation Assets
31 Jul 2024 //
GLOBENEWSWIRE
BioSig Improves Balance Sheet, Reduces Payables In Q2 2024
25 Jul 2024 //
GLOBENEWSWIRE
BioSig Appoints Ferdinand Groenewald As Interim CFO And Accounting Officer
10 Jun 2024 //
GLOBENEWSWIRE
BioSig Announces $3M Direct Offering Per Nasdaq
30 May 2024 //
GLOBENEWSWIRE
BioSig Closes $3M Direct Offering At-The-Market Per Nasdaq
30 May 2024 //
GLOBENEWSWIRE
BioSig CEO Issues Shareholder Letter
21 May 2024 //
GLOBENEWSWIRE
BioSig Announces New 5-Member Board, 3 Independent Directors
03 May 2024 //
GLOBENEWSWIRE
BioSig Appoints Anthony Amato As CEO, Effective Immediately
30 Apr 2024 //
GLOBENEWSWIRE
BioSig Engages Consulting Firm for Business Model Strategies
04 Apr 2024 //
GLOBENEWSWIRE
BioSig Announces Reduction of its Workforce
20 Feb 2024 //
GLOBENEWSWIRE
BioSigs PURE Platform with Field Tracking Algorithm Surpasses 100 Patient Cases
06 Feb 2024 //
GLOBENEWSWIRE
BioSig Announces Reverse Stock Split
31 Jan 2024 //
GLOBENEWSWIRE
BioSig Announces Cost Reductions to Improve its Financial Standing
30 Jan 2024 //
GLOBENEWSWIRE
BioSig Issues Letter to Shareholders Detailing Technology Innovations
06 Dec 2023 //
GLOBENEWSWIRE
BioSig Announces $2.5 Million Registered Direct Offering
13 Nov 2023 //
GLOBENEWSWIRE
BioSig Announces $2.5 Million Registered Direct Offering
09 Nov 2023 //
GLOBENEWSWIRE
BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VP
07 Nov 2023 //
GLOBENEWSWIRE
BioSig™s New PURE EP Subscription Model Adopted by Mayo Clinic-Phoenix
02 Nov 2023 //
GLOBENEWSWIRE
BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio
01 Nov 2023 //
GLOBENEWSWIRE
BioSig Achieves Infrastructure progress in Development of Generative AI Platform
24 Aug 2023 //
GLOBENEWSWIRE
BioSig Introduces New Subscription Model for PURE EP Platform
23 Aug 2023 //
GLOBENEWSWIRE
BioSig`s PURE EP„¢ Platform Debuts New Automated Features in First Patient Cases
22 Aug 2023 //
GLOBENEWSWIRE
BioSig AI Receives $2.2 Million in Seed Funding to Advance AI Applications
25 Jul 2023 //
GLOBENEWSWIRE
BioSig AI Selected for NVIDIA Inception Program to Support R&D Collaboration
20 Jul 2023 //
GLOBENEWSWIRE
BioSig Joins Webull Corporate Connect
29 Jun 2023 //
GLOBENEWSWIRE
BioSig Advances Collaboration on Machine Learning and AI Solutions
27 Jun 2023 //
GLOBENEWSWIRE
BioSig to Highlight New Data from the PURE EP„¢ Platform at Heart Rhythm 2023
03 May 2023 //
GLOBENEWSWIRE
BioSig Announces New Advisory Board Member Edwin Wang
27 Mar 2023 //
GLOBENEWSWIRE
BioSig Announces New Advisory Board Member Lorraine Spurge
24 Mar 2023 //
GLOBENEWSWIRE
BioSig Confirms No Exposure to Silicon Valley Bank
13 Mar 2023 //
GLOBENEWSWIRE
BioSig Regains Compliance With All Nasdaq Listing Standards
22 Feb 2023 //
GLOBENEWSWIRE
BioSig Awarded US Patent Claims for its Universal Notch Filter Technology
17 Feb 2023 //
GLOBENEWSWIRE
BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy
07 Feb 2023 //
GLOBENEWSWIRE
BioSig Issues Shareholder Update to Highlight Recent Achievements
19 Jan 2023 //
GLOBENEWSWIRE
BioSig Executes Agreement with Bellin Health for Acquisition of its PURE EP Tech
10 Jan 2023 //
GLOBENEWSWIRE
BioSig’s PURE EP System Demonstrates Potential Time and Cost Savings
14 Dec 2022 //
GLOBENEWSWIRE
BioSig’s PURE EP System Demonstrates Potential Time at 15th APHRS in Singapore
14 Dec 2022 //
GLOBENEWSWIRE
BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation
06 Dec 2022 //
GLOBENEWSWIRE
BioSig Signs Master Research Agreement with Cleveland Clinic
24 Oct 2022 //
GLOBENEWSWIRE
BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022
12 Oct 2022 //
GLOBENEWSWIRE
BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio
07 Oct 2022 //
GLOBENEWSWIRE
BioSig Strengthens Marketing and Sales Teams, Appoints National Account
30 Aug 2022 //
GLOBENEWSWIRE
BioSig Places Second PURE EP System For Evaluation at Cleveland Clinic
24 Aug 2022 //
GLOBENEWSWIRE
BioSig’s Processing Technology To Be Featured at Rhythm Symposium 2022
17 Aug 2022 //
GLOBENEWSWIRE
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute
07 Jul 2022 //
GLOBENEWSWIRE
BioSig Announces Closing of Public Offering of Common Stock
29 Jun 2022 //
GLOBENEWSWIRE
BioSig Announces Pricing of Public Offering of Common Stock
24 Jun 2022 //
GLOBENEWSWIRE
BioSig Announces Proposed Public Offering of Common Stock
23 Jun 2022 //
GLOBENEWSWIRE
BioSig Advances its PURE System Commercial Launch to Medical Centers Nationwide
26 May 2022 //
GLOBENEWSWIRE
BioSig`s PURE EP System to be Featured During EPLive 2022
25 May 2022 //
GLOBENEWSWIRE
BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements
11 May 2022 //
GLOBENEWSWIRE
BioSig to Present at Heart Rhythm 2022
19 Apr 2022 //
GLOBENEWSWIRE
BioSig to Present at NobleCon18 Capital Markets Conference
07 Apr 2022 //
GLOBENEWSWIRE
BioSig Technologies Partners with Summit Blue Capital
29 Mar 2022 //
GLOBENEWSWIRE
BioSig Announces Closing of Public Offering of Common Stock
23 Mar 2022 //
GLOBENEWSWIRE
BioSig Technologies, Inc. Appoints John Sieckhaus as Chief Operating Officer
16 Mar 2022 //
GLOBENEWSWIRE
BioSig Awarded US Patent Claims for its PURE EP™ Noise-Filtering Technology
26 Jan 2022 //
GLOBENEWSWIRE
BioSig Selects Access Strategy Partners to Accelerate Commercial Sales
21 Dec 2021 //
GLOBENEWSWIRE
